Teladoc Health, Inc.
TDOC
$9.00
$0.0650.73%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -0.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -0.30% | |||
| Cost of Revenue | 5.11% | -4.42% | |||
| Gross Profit | -2.00% | 1.40% | |||
| SG&A Expenses | -3.46% | 2.70% | |||
| Depreciation & Amortization | -0.06% | -7.24% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.26% | -1.56% | |||
| Operating Income | -4.44% | 17.94% | |||
| Income Before Tax | -48.24% | 96.10% | |||
| Income Tax Expenses | -69.49% | -79.92% | |||
| Earnings from Continuing Operations | -45.48% | 96.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -45.48% | 96.03% | |||
| EBIT | -4.44% | 17.94% | |||
| EBITDA | -12.04% | -19.40% | |||
| EPS Basic | -44.43% | 96.06% | |||
| Normalized Basic EPS | -46.87% | 32.49% | |||
| EPS Diluted | -44.43% | 96.06% | |||
| Normalized Diluted EPS | -46.87% | 32.49% | |||
| Average Basic Shares Outstanding | 0.74% | 0.74% | |||
| Average Diluted Shares Outstanding | 0.74% | 0.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
